The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|235|2|355-367

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.235, Iss.2, 2015-01, pp. : 355-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combining albumin‐bilirubin score with future liver remnant predicts post‐hepatectomy liver failure in HBV‐associated HCC patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 3, 2018-03 ,pp. : 494-502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer Therapy

By  

Recent Patents on CNS Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 94-103

Bentham Science Publishers

Access to resources Recommend Favorite

Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct‐acting antiviral treatment for HCV

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 76-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians

By Lin Hillary   Ha Nghiem   Ahmed Aijaz   Ayoub Walid   Daugherty Tami   Lutchman Glen   Garcia Gabriel   Nguyen Mindie  

Journal of Immigrant and Minority Health, Vol. 15, Iss. 6, 2013-12 ,pp. : 1023-1029

Springer Publishing Company

Access to resources Recommend Favorite

Response to ‘Can indirect non‐invasive markers or models replace liver biopsy?’

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 682-683

John Wiley & Sons Inc

Access to resources Recommend Favorite